NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Spatial transcriptomics: Visium Spatial RNA Sequencing Analytical Performance (Mt Sinai)   Add to my SOP compendium

BRD ID: 3,118

Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 11

Description

This assay analytical validation and performance report describes the methods used to validate the Visium spatial RNA sequencing assay for the analysis of formalin-fixed, paraffin-embedded (FFPE) tissue sections. The document includes acceptable thresholds for RNA quality (DV200) and QC sequencing metrics and a comparison of data generated from FFPE and OCT-embedded frozen tissue specimens. Data that supports the reported reproducibility is also presented. It is used by the Cancer Immune Monitoring and Analysis Center (CIMAC) at Icahn School of Medicine at Mount Sinai. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm), a Cancer Moonshot Initiative.

Documents for Download

Analytical Report_Visium10x_09142022_Mt Sinai_508_Final.pdf [Size: 1919 KB]

Biospecimens
  • Tissue - General
  • Tissue - Not specified
Diagnoses
  • Not specified
  • Neoplastic - Not specified
Topics
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • More...